Clinical and laboratorial profile and complications of patients with HELLP syndrome admitted in an obstetric intensive care unit;Perfil clínico, laboratorial e complicações de pacientes com síndrome HELLP admitidas em uma unidade de terapia intensiva obstétrica

Revista Brasileira de Ginecologia e Obstetricia

Volumn 30, Issue 2, 2008, Pages 80-86

  Katz, Leila ^a,b,f   De Amorim, Melania Maria Ramos ^b,c   Miranda, Giselly Veríssimo ^d,e   Silva, João Luiz Pinto ^a,e  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF CAMPINA GRANDE   (Brazil)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^e Fellow of the National Research Council

^f NONE   (Brazil)

Author keywords

Dexamethasone therapeutic use; HELLP syndrome complications; HELLP syndrome drug therapy; Intensive care units; Pre eclampsia; Pregnancy complications; Prognosis

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HELLP SYNDROME; HOSPITAL DEPARTMENT; HUMAN; INTENSIVE CARE UNIT; MIDDLE AGED; PREGNANCY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HELLP SYNDROME; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; OBSTETRICS AND GYNECOLOGY DEPARTMENT, HOSPITAL; PREGNANCY; YOUNG ADULT;

EID: 45749102472     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-72032008000200006     Document Type: Article

References (30)

1. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Washington, D.C: The College; 1996. Technical Bulletin, 219.
2. Weistein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159-67.
3. Williams KP, Wilson S. Ethnic variation in the incidence of HELLP syndrome in a hypertensive pregnant population. J Perinat Med. 1999;25(6):498-501.
4. Magann EF, Martin JN Jr. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol. 1999;42(3):532-50.
5. Suresh MS. HELLP syndrome: an anesthesiologist's perspective. Anesthesiol Clin North Am. 1998;16(2):332-48.
6. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990;162(2):311-6.
7. Santos LC, Amorim MMR, Katz L, Albuquerque CJM. Terapia intensiva em obstetrícia. Rio de Janeiro: Medsi; 2004. p. 63-75.
8. Vigil-De Gracia P, García-Cáceres E. Dexamethasone in the post-partum treatment of HELLP syndrome. Int J Gynaecol Obstet. 1997;59(3):217-21.
9. Yalcin OT, Sener T, Hassa H, Ozalp S, Okur A. Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynaecol Obstet. 1998;61(2):141-8.
10. Katz L. Uso da dexametasona em pacientes com síndrome hellp: ensaio clínico randomizado controlado com placebo [tese]. Campinas: Universidade de Campinas; 2007.
11. Mecacci F, Carignani L, Cioni R, Parreti E, Mignosa M, Piccioli A, et al. Time course of recovery and complications of HELLP syndrome with two different treatments: heparin or dexamethasone. Thromb Res. 2001;102(2):99-105.
12. Goodwin AA, Mercer BM. Does maternal race or ethnicity affect the expression of severe preeclampsia? Am J Obstet Gynecol. 2005;193(3 Pt 2):973-8.
13. Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol. 2000;183(2):444-8.
14. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1999;181(4):924-8.
15. Vallejo Maroto I, Miranda Guisado ML, Stiefel García-Junco P, Pamies Andreu E, Marenco ML, Castro de Gavilan D, et al. Clinical and biological characteristics of a group of 54 pregnant women with HELLP syndrome. Med Clin (Barc). 2004;122(7):259-61.
16. Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999;180(6 Pt 1):1373-84.
17. Romero Arauz JF, Lara Gonzalez AL, Ramos Leon JC, Izquierdo Puente JC. Maternal morbidity and mortality in HELLP syndrome. Ginecol Obstet Mex. 2001;69:189-93.
18. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1996;175(2):460-4.
19. Helguera-Martínez AM, Tenorio-Marañón R, Vigil-de Gracia PE, García-Cáceres E. HELLP syndrome. Analysis of 102 cases. Ginecol Obstet Mex. 1996;64:528-33.
20. Sibai BM, Taslami MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome hemolysis, elevated liver enzymes, and low platelets in severe preeclampsiaeclampsia. Am J Obstet Gynecol. 1986;155(3):501-9.
21. Isler CM, Barrilleaux PS, Magann EF, Bass JD, Martin JN Jr. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol. 2001;184(7):1332-7.
22. Fonseca JE, Mendez F, Catano C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005;193(5):1591-8.
23. Basavilvazo Rodríguez A, Pacheco Pérez C, Lemus Rocha R, Martínez Pérez JM, Martínez Martínez A, Hernández-Valencia M. Maternal and perinatal surgical complications in low platelet count for HELLP syndrome in severe preeclampsia-eclampsia in intensive care. Ginecol Obstet Mex. 2003;71:379-86.
24. Malvino E, Muñoz M, Ceccotti C, Janello G, Mc Loughlin D, Pawlak A, et al. Maternal morbidity and perinatal mortality in HELLP syndrome. Multicentric studies in intensive care units in Buenos Aires area. Medicina (B Aires). 2005;65(1):17-23.
25. Sibai BM. Hypertension. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 4th ed. New York: Churchill Livingstone; 2002. p. 945-1004.
26. Briggs R, Chari RS, Mercer B, Sibai B. Postoperative incision complications after cesarean section in patients with antepartum syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): does delayed primary closure make a difference? Am J Obstet Gynecol. 1996;175(4 Pt 1):893-6.
27. Martin JN Jr, Perry KG Jr, Blake PG, May WA, Moore A, Robinette L. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol. 1997;177(5):1011-7.
28. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal-morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169(4):1000-6.
29. Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y. Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure. Ren Fail. 2004;26(5):557-62.
30. Martínez de Ita AL, García Cáceres E, Helguera Martínez AM, Cejudo Carranza E. Acute renal insufficiency in HELLP syndrome. Ginecol Obstet Mex. 1998;66:462-8.